|
Apricus Biosciences Enters Into Common Stock Purchase Agreement With …
MarketWatch Apricus Biosciences, Inc. (NASDAQ:APRI) (the “Company” or “Apricus”), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced it has entered into a common stock purchase agreement with Aspire Capital … |
